Environmental life cycle assessment of nanosilver-enabled bandages

Over 400 tons of silver nanoparticles (AgNPs) are produced annually, 30% of which are used in medical applications due to their antibacterial properties. The widespread use of AgNPs has implications over the entire life cycle of medical products, from production to disposal, including but not limited to environmental releases of nanomaterials themselves. Here a cradle-to-grave life cycle assessment from nanoparticle synthesis to end-of-life incineration was performed for a commercially available nanosilver-enabled medical bandage. Emissions were linked to multiple categories of environmental impacts, making primary use of the TRACI 2.1 impact assessment method, with specific consideration of nanosilver releases relative to all other (non-nanosilver) emissions. Modeling results suggest that (1) environmental impacts of AgNP synthesis are dominated by upstream electricity production, with the exception of life cycle ecotoxicity where the largest contributor is mining wastes, (2) AgNPs are the largest contributor to impacts of the bandage for all impact categories considered despite low AgNP loading, and (3) impacts of bandage production are several times those bandage incineration, including nanosilver releases to the environment. These results can be used to prioritize research and policy measures in order to improve the overall ecotoxicity burdens of nanoenabled products under a life cycle framework.